enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · IEX Real-Time Price · USD
13.14
-0.08 (-0.61%)
May 23, 2024, 4:30 PM EDT - Market closed

enGene Holdings Income Statement

Millions USD. Fiscal year is Nov - Oct.
Year 2023202220212020
Selling, General & Admin
9.63.963.413.24
Research & Development
16.4615.4712.4610.61
Operating Expenses
26.0619.4315.8713.85
Operating Income
-26.06-19.43-15.87-13.85
Interest Expense / Income
4.951.425.023.7
Other Expense / Income
68.893.592.55-2.48
Pretax Income
-99.9-24.44-23.44-15.07
Income Tax
0.020.0200
Net Income
-99.92-24.46-23.44-15.07
Preferred Dividends
4.824.56-1.191.58
Net Income Common
-104.74-29.02-22.25-16.65
Shares Outstanding (Basic)
1143
Shares Outstanding (Diluted)
1143
Shares Change
5.72%-81.61%28.93%-
EPS (Basic)
-151.22-44.30-6.25-6.02
EPS (Diluted)
-151.22-44.30-6.25-6.02
Free Cash Flow
-25.06-17.75-16.23-13.25
Free Cash Flow Per Share
-36.18-27.09-4.56-4.80
EBITDA
-94.77-22.78-18.17-11.12
Depreciation & Amortization
0.180.230.250.25
EBIT
-94.95-23.02-18.42-11.37
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).